Diagnostic and Prognostic Markers in Liver Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 1567
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to delve into the rapidly evolving field of biomarkers, with a focus on liver diseases of various etiologies including metabolic, alcoholic, and autoimmune pathologies. It seeks to highlight advancements in molecular, genetic, biochemical, and imaging markers that enhance diagnosis, and/or accurately predict disease progression, treatment response, and patient outcomes. Therefore, we cordially invite you to submit comprehensive reviews and original research articles covering the discovery, validation, and clinical translation of these markers. We are particularly interested in contributions exploring innovative non-invasive markers, novel imaging techniques, and emerging laboratory methods. Emphasis will also be placed on the integration of these markers in clinical practice, their potential role in personalized medicine. Our goal is to provide a multidisciplinary platform for scientists and clinicians to share and discuss novel discoveries that will shape future diagnostic and therapeutic strategies in hepatology.
We look forward to receiving your contributions.
Dr. Dávid Tornai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnostic and prognostic markers
- non-invasive biomarkers
- hepatology
- liver disease
- therapeutic response
- disease progression
- fibrosis
- mortality
- decompensation
- infection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
